All In Biotech

Drug Trial Radar · NCT00216385

A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

A Randomised Open-Label Controlled Trial of a 4-Month Gatifloxacin-Containing Regimen Versus Standard Regimen for the Treatment of Adult Patients With Pulmonary Tuberculosis

Last checked: Nov 20, 2026Latest source record: Sep 22, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 2,070 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,070

Actual

Start

Jan 2005

Primary completion

Not stated

Study completion Dec 2008

Sponsor

Lead sponsor
Institut de Recherche pour le DeveloppementGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
World Health Organization; European Commission
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Tuberculosis is currently treated with a 6-month course regimen. During this time many patients might fail to adhere to treatment and default, increasing the risk of recurrent disease which might be multidrug resistant. A shorter duration of treatment is expected to provide improved patient compliance and at least equal or better clinical outcome. The aim of the trial is to evaluate the efficacy and safety of a gatifloxacin-containing regimen of four months duration for the treatment of pulmonary tuberculosis,

Conditions

  • Tuberculosis

Interventions

  • Gatifloxacin combined regimenDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy: Percentage of relapses by 24 months following treatment cure
  2. Safety: Percentage of adverse events

Locations

5 sites in 5 countries. Site status is shown where the registry gives one.

  • Programme National de Lutte contre la Tuberculose

    Cotonou, Benin · Recruiting

  • Service Pneumo-Phtisiologie, CHU Ignace Deen

    Conakry, Guinea · Recruiting

  • Kenya Medical Research Institute

    Nairobi, Kenya · Recruiting

  • Programme National de Lutte contre la Tuberculose

    Dakar, Senegal · Recruiting

  • Medical Research Council

    Durban, KwaZulu, South Africa · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.